Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    MATISSE
Show Display Options
Rank Status Study
1 Completed PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Conditions: Choroidal Neovascularization;   Diabetic Retinopathy;   Diabetic Macular Edema
Interventions: Drug: PF-04523655 (Stratum I);   Drug: ranibizumab;   Drug: PF-04523655 (Stratum II)
2 Active, not recruiting Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study)
Condition: Extensive-Stage Small Cell Lung Cancer
Interventions: Drug: Carboplatin;   Drug: Palifosfamide-tris;   Drug: Etoposide

Indicates status has not been verified in more than two years